 WILMINGTON, Del., Aug. 11, 2020 GLOBE NEWSWIRE -- Rigrodsky Long, P.A. announces that it is investigating Pfenex Inc. Pfenex NYSE American: PFNX regarding possible breaches of fiduciary duties and other violations of law related to Pfenexs agreement to be acquired by Ligand Pharmaceuticals Incorporated NASADAQ GM: LGND. Under the terms of the agreement, shareholders of Pfenex will receive 12.00 in cash and one contingent value right CVR for each share of Pfenex they own. To learn more about this investigation and your rights, visit: you would like to discuss this investigation and your rights cost and obligation free, please contact Seth D. Rigrodsky or Gina M. Serra toll free at 888 969-4242 or by e-mail at Rigrodsky Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.Attorney advertising. Prior results do not guarantee a similar outcome.CONTACT: Rigrodsky Long, P.A. Seth D. Rigrodsky Gina M. Serra 888 969-4242 Toll Free 302 295-5310 Fax: 302 654-7530 